Hydroxynaphthalenecarboxamides and substituted piperazinylpropandiols, two new series of BRAF inhibitors. A theoretical and experimental study (original) (raw)

BRAF inhibitors: From the laboratory to clinical trials

Alfred Lam

Critical Reviews in Oncology/Hematology, 2013

View PDFchevron_right

Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022

Mariusz Jaremko

ACS Omega, 2023

View PDFchevron_right

Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques

Ludmila Campos

Bioorganic Chemistry, 2019

View PDFchevron_right

Small molecule inhibitors of BRAF in clinical trials

Ion Niculescu-duvaz

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

The multifaceted anti-cancer effects of BRAF-inhibitors

Laura Croce

Oncotarget

View PDFchevron_right

A cell-based screening to detect inhibitors of BRAF signaling pathway

Mihoko Mori

Journal of Antibiotics, 2009

View PDFchevron_right

BRAF Inhibitors and Control of Mutant BRAF Effects

Nahla Hamed

Cancer therapy & oncology international journal, 2023

View PDFchevron_right

Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors

Dong Li

Bioorganic & Medicinal Chemistry, 2012

View PDFchevron_right

Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor

Gabriel Schnetzler

Clinical Cancer Research, 2021

View PDFchevron_right

BRAF inhibitors - do we need to worry about kidney injury?

Craig Devoe

Expert Opinion on Drug Safety, 2016

View PDFchevron_right

Data from Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor

Gabriel Schnetzler

2023

View PDFchevron_right

3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors

Frederik Rombouts

Bioorganic & Medicinal Chemistry Letters, 2020

View PDFchevron_right

Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring

Adrian Gill

Journal of Medicinal Chemistry, 2009

View PDFchevron_right

What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

Enrico Bronte

Oncotarget, 2015

View PDFchevron_right

Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors

Filipa Lopes

Journal of medicinal …, 2010

View PDFchevron_right

4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors

Merryl Cramer

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives

Anny USHEVA

Cancer Research, 2008

View PDFchevron_right

Functional characterization of a PROTAC directed against BRAF mutant V600E

David Uehling

Nature Chemical Biology, 2020

View PDFchevron_right

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

Merryl Cramer

Molecular Cancer Therapeutics, 2012

View PDFchevron_right

Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)

Richard Kefford, Melvin T M Chin

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014

View PDFchevron_right

Mechanism of Dimer Selectivity and Binding Cooperativity of BRAF inhibitors

evangelia matenoglou

bioRxiv (Cold Spring Harbor Laboratory), 2023

View PDFchevron_right

Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors

Gaetana Rinaldi

Pharmacology & therapeutics, 2018

View PDFchevron_right

Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor

Zhenquan Hu

European journal of medicinal chemistry, 2017

View PDFchevron_right

Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk

Constantin Neagu

Bioorganic & Medicinal Chemistry Letters, 2018

View PDFchevron_right

Data from Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)

Daniele Ouellet

View PDFchevron_right

Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization

suresh babu

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

BRAF inhibitor resistance: are holidays and cocktails the answer?

Christopher Caunt

Pigment Cell & Melanoma Research, 2014

View PDFchevron_right

Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds

Arnaud Nourry

Bioorganic & Medicinal Chemistry, 2010

View PDFchevron_right

In vitro and in vivo profiling of CHF5022 and CHF5074

B. Imbimbo

Pharmacological Research, 2007

View PDFchevron_right

Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets

Anuradha Mittal

Analytical Biochemistry, 2012

View PDFchevron_right